methional has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chantepie, J; Fournet, G; Giliberto, JP; Goré, J; Hiltbrand, E; Mehier, H; Morel, D; Paret, MJ; Quash, G; Reichert, U; Rochedix, ME | 1 |
| Chantepie, J; Courvoisier, C; Fournet, G; Goré, J; Paret, MJ; Quash, G | 1 |
2 other study(ies) available for methional and Cancer of Prostate
| Article | Year |
|---|---|
Synergetic bitherapy in mice with xenografts of human prostate cancer using a methional mimic (METLICO) and an aldehyde dehydrogenase 3 inhibitor (MATE): systemic intraperitoneal (IP) and targeted intra-tumoral (IT) administration.
Topics: Aldehyde Dehydrogenase; Aldehydes; Animals; Biomimetics; Combined Modality Therapy; Drug Delivery Systems; Enzyme Inhibitors; Female; Humans; Injections, Intralesional; Injections, Intraperitoneal; Male; Mice; Mice, Nude; Molecular Structure; Morpholines; Prostatic Neoplasms; Quinazolines; Tumor Burden | 2009 |
Synthesis and effects of 3-methylthiopropanoyl thiolesters of lipoic acid, methional metabolite mimics.
Topics: Aldehydes; Antineoplastic Agents; Esters; Humans; Inhibitory Concentration 50; Male; Methionine; Molecular Mimicry; Propionates; Prostatic Neoplasms; Sulfhydryl Compounds; Thioctic Acid; Tumor Cells, Cultured | 2006 |